These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4426641)

  • 1. Humoral & cell mediated immunity to leukemia specific antigens in an inbred mouse strain showing spontaneous leukemia & mammary tumors.
    Vissa B; Gangal SG
    Indian J Exp Biol; 1974 Jan; 12(1):12-4. PubMed ID: 4426641
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological relationship between antigens induced by leukemia virus & mammary tumor virus in an inbred mouse strain.
    Vissa B; Gangal SG
    Indian J Exp Biol; 1974 Jan; 12(1):5-7. PubMed ID: 4372168
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH; Calabresi P
    J Natl Cancer Inst; 1972 Apr; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract]   [Full Text] [Related]  

  • 4. Humoral and cellular immune responses to mouse mammary tumor virus (MMTV) in experimental animal models (review).
    Lopez DM
    Anticancer Res; 1984; 4(4-5):305-12. PubMed ID: 6091529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between the tumor-specific antigen and cytological characteristics in mouse mammary tumors.
    Irie RF; Koyama K; Hino S
    J Natl Cancer Inst; 1970 Sep; 45(3):515-24. PubMed ID: 5523194
    [No Abstract]   [Full Text] [Related]  

  • 6. Embryonic antigens in tumor immunity.
    Della Porta G
    Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of H-2 histocompatibility on generation of cell-mediated cytotoxicity against virus-induced mammary tumors in C3H mice.
    Stutman O
    Transplant Proc; 1977 Mar; 9(1):1153-5. PubMed ID: 194369
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of tumor growth and cell-mediated immune responses of mice bearing mammary tumors following surgical procedures.
    Lopez DM; Sigel MM
    J Reticuloendothel Soc; 1975 Nov; 18(5):305-12. PubMed ID: 1206665
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on specific humoral immunity in leukemia.
    Bergolz VM
    Neoplasma; 1976; 23(5):457-62. PubMed ID: 790209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral host defense mechanisms against tumors.
    Ting CC; Herberman RB
    Int Rev Exp Pathol; 1976; 15():93-152. PubMed ID: 176124
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune response to rauscher virus-induced leukemia in DBA mice. I. Role of cellular and humoral immunity in spontaneous regression.
    Tóth FD; Gomba S; Váczi L; Kása M; Jakó J
    Neoplasma; 1976; 23(5):471-81. PubMed ID: 980178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS; Radov LA; Yamamura Y; Parthenais E; Korn JH; Ritter FL
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic cross-reactivity between primary spontaneous mouse mammary tumors and their transplantable ascites tumors.
    Irie RF
    Cancer Res; 1971 Nov; 31(11):1682-9. PubMed ID: 4330634
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.
    Baldwin RW; Embleton MJ; Robins RA
    Proc R Soc Med; 1973 May; 66(5):466-8. PubMed ID: 4351926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.